Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

Influencer Rea Strawhill talks chronic illness advocacy online!

Creating safe space for people with chronic illness on social media:

An interview with advocate & person with ME: Rea Strawhill

As part of this year’s Triple Giving Tuesday campaign, we are honored to highlight the work of chronic illness advocate Rea Strawhill, who uses social media to boldly raise awareness of ME/CFS and related chronic, complex diseases. 

With 14,000 followers on Instagram alone, Rea is committed to ending the stigma of disability, educating others, and helping people within the #ChronicIllnessCommunity feel less alone. Recently, she chatted with us about her social media advocacy, life with ME/CFS, and more:

How long have you been living with ME/CFS? 

I was diagnosed in 2019, but the onset of the illness was probably already in 2011 after an infection with the Epstein Barr virus. After the infection, the symptoms never fully went away, but since they were “only” mild at the time, nobody took it seriously. I only got the diagnosis years later, after my symptoms got much worse. It took a long time for me to find out what I was dealing with, so getting the diagnosis was both a shock and a relief. 

As a young person living with a chronic illness that is often invisible, what are some of the challenges you have faced?

It is a shame that young women with health conditions have to fight to be taken seriously. So often, we are told that we are “drama queens.” 

Many doctors downplayed my struggles, and when they didn’t find anything wrong, they immediately assumed that it must be “in my head.” I don’t want to downplay mental illnesses, but it was not what was happening in my case, and being medically gaslit like this was extremely hurtful and invalidating. It shouldn’t have taken me years to find a doctor who listened and took a closer look.

Can you tell us about how you got started advocating for those with chronic illnesses? 

It was shocking to learn about ME​/​CFS and that so many people suffer from it — yet I had never heard of it. Writing about it was almost therapeutic. I needed to get my thoughts and feelings out there. I felt so helpless, and I thought that if I could raise some awareness about this, it was at least something that I could do. I never thought it would resonate with so many people and that thousands of others are going through this. It encouraged me to keep raising awareness and get the word out there.

It has been very eye-opening to see how many people are out there who have similar experiences, and it has given me a lot of strength to know that I am not alone and that there are people out there who have my back.

Have you felt that posting about chronic illness on social media has been a powerful tool to help educate others that don’t understand?

It is sometimes scary to be so open about your personal life on the internet, but I gained so much from it, which has strengthened me. I sometimes get messages from people thanking me for what I do and telling me that they now better understand their chronically ill friends or family members. That means the world to me and tells me that what I am doing makes a difference.

What are your hopes for the future of your social media advocacy?

I am hoping to get the message out that people realize and understand how we struggle, how we as a society could support chronically ill people better and make the world more inclusive for us.

Ultimately, social media has created a safe space for me and helped me realize that I am worthy just the way I am. I hope it can help others feel the same.

There's no better time to give — Your gift of any amount will be tripled from now until November 30, 2021, giving you the exciting opportunity to accelerate these critical research projects and provide hope for millions living with multisystem chronic, complex illnesses worldwide.

Support these innovative projects by donating to OMF's 2021
#TripleGivingTuesday campaign today!

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

Averting a second pandemic:

Open Medicine Foundation leads groundbreaking international study of

Long COVID’s conversion to ME/CFS

AGOURA HILLS, CALIF.  — Open Medicine Foundation (OMF) is leading a large-scale international collaborative study investigating the potential conversion of Post-Acute Sequelae SARS-CoV-2 infection — more commonly known as Long COVID or Post-COVID Syndrome —  to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic, life-altering disease with no known cause, diagnostic test or FDA approved treatments available.

Up to 2.5 million people in the U.S. alone suffer from ME/CFS; the COVID-19 pandemic could at least double that number. An estimated 35 percent of Americans who had COVID-19 have failed to fully recover several months after infection, prompting many to call it “a potential second pandemic.”

OMF recognized a familiar health crisis emerging, one with eerie similarities to ME/CFS. This crisis presented a unique opportunity to understand how a viral infection — in this case COVID-19 — may develop into ME/CFS in some patients. The goal is to find targeted treatments for ME/CFS patients and ultimately prevent its onset in people infected with SARS-CoV-2 or other infections.

The federal government is only now investing in Post-COVID research, with no focus on its connection to ME/CFS. OMF has already engaged researchers for the largest-scale study of its kind, solely supported by private donors who have contributed over one million dollars to date. When fully funded, the five million dollar, three-year study will be conducted across the globe at OMF funded Collaborative Research Centers, led by some of the world’s top researchers and ME/CFS experts.


In a significant percentage of patients, infections preceded their development of ME/CFS.  For example, according to the CDC about one in ten infected with Epstein-Barr virus, Ross River virus, or Coxiella burnetti develop symptoms that meet the criteria for ME/CFS.


The ability to follow the development of ME/CFS from a known viral infection is unprecedented to date and crucial to researchers’ understanding of the disease. The focus of this study is to find the biological differences between persons returning to good health after COVID-19 and persons who remained ill more than six months after infection and developed ME/CFS.  Understanding these alterations in key pathways can lead to groundbreaking discoveries including new biomarkers, drug targets, and prevention and treatment strategies.


About Open Medicine Foundation

Established in 2012, Open Medicine Foundation leads the largest, concerted worldwide nonprofit effort to diagnose, treat, and prevent ME/CFS and related chronic, complex diseases such as Post Treatment Lyme Disease Syndrome, Fibromyalgia, and Post COVID. OMF adds urgency to the search for answers by driving transformational philanthropy into global research. We have raised over $28 Million from private donors and facilitated and funded the establishment of six prestigious ME/CFS Collaborative Research Centers around the world. To learn more, visit www.omf.ngo.


Heather Ah San

Development and Communications Manager